Fasting Study of Propranolol Hydrochloride Extended-Release Capsules 160 mg and Inderal® LA Capsules 160 mg

NCT00647816 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

100

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: Propranolol Hydrochloride Extended-Release Capsules 160 mg
DRUG: Inderal® LA Capsules 160 mg

Sponsor

Mylan Pharmaceuticals Inc